185 related articles for article (PubMed ID: 37445668)
61. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
[TBL] [Abstract][Full Text] [Related]
62. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
63. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma.
Lee L; Draper B; Chaplin N; Philip B; Chin M; Galas-Filipowicz D; Onuoha S; Thomas S; Baldan V; Bughda R; Maciocia P; Kokalaki E; Neves MP; Patel D; Rodriguez-Justo M; Francis J; Yong K; Pule M
Blood; 2018 Feb; 131(7):746-758. PubMed ID: 29284597
[TBL] [Abstract][Full Text] [Related]
64. [Role of B-cell-activating-factor in immune regulation--review].
Du JF; Wang JX; Xu DG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):631-4. PubMed ID: 16800959
[TBL] [Abstract][Full Text] [Related]
65. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Novak AJ; Darce JR; Arendt BK; Harder B; Henderson K; Kindsvogel W; Gross JA; Greipp PR; Jelinek DF
Blood; 2004 Jan; 103(2):689-94. PubMed ID: 14512299
[TBL] [Abstract][Full Text] [Related]
66. B cell activating factor (BAFF) and BAFF receptors: fakes and facts.
Ferraccioli G; Gremese E
Clin Exp Immunol; 2017 Dec; 190(3):291-292. PubMed ID: 28834574
[TBL] [Abstract][Full Text] [Related]
67. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
68. B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
Spinelli FR; Barbati C; Cecarelli F; Morello F; Colasanti T; Vomero M; Massaro L; Orefice V; Alessandri C; Valesini G; Conti F
Arthritis Res Ther; 2019 Nov; 21(1):245. PubMed ID: 31752963
[TBL] [Abstract][Full Text] [Related]
69. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression.
Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046
[TBL] [Abstract][Full Text] [Related]
70. BAFF is increased in renal transplant patients following treatment with alemtuzumab.
Bloom D; Chang Z; Pauly K; Kwun J; Fechner J; Hayes C; Samaniego M; Knechtle S
Am J Transplant; 2009 Aug; 9(8):1835-45. PubMed ID: 19522878
[TBL] [Abstract][Full Text] [Related]
71. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.
Smets I; Prezzemolo T; Imbrechts M; Mallants K; Mitera T; Humblet-Baron S; Dubois B; Matthys P; Liston A; Goris A
Front Immunol; 2021; 12():676619. PubMed ID: 34122439
[TBL] [Abstract][Full Text] [Related]
72. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.
Salzer U; Grimbacher B
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):496-503. PubMed ID: 16264328
[TBL] [Abstract][Full Text] [Related]
73. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
74. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
Nys J; Smulski CR; Tardivel A; Willen L; Kowalczyk C; Donzé O; Huard B; Hess H; Schneider P
PLoS One; 2013; 8(4):e61350. PubMed ID: 23620746
[TBL] [Abstract][Full Text] [Related]
75. Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells.
Jacobs HM; Thouvenel CD; Leach S; Arkatkar T; Metzler G; Scharping NE; Kolhatkar NS; Rawlings DJ; Jackson SW
J Immunol; 2016 May; 196(9):3525-31. PubMed ID: 27022196
[TBL] [Abstract][Full Text] [Related]
76. B cell-activating factor regulates the survival of B lymphocytes infected with human cytomegalovirus.
Xu H; Dong P; Ma X; Song D; Xue D; Xu R; Lu H; He X
Immunol Lett; 2017 Jul; 187():1-6. PubMed ID: 28442365
[TBL] [Abstract][Full Text] [Related]
77. The activation of BAFF/APRIL system in spleen and lymph nodes of Plasmodium falciparum infected patients.
Dechkhajorn W; Benjathummarak S; Glaharn S; Chaisri U; Viriyavejakul P; Maneerat Y
Sci Rep; 2020 Mar; 10(1):3865. PubMed ID: 32123265
[TBL] [Abstract][Full Text] [Related]
78. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
79. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
Abo-Elfadl MT; Gamal-Eldeen AM; Ismail MF; Shahin NN
Cytokine; 2020 Jan; 125():154790. PubMed ID: 31400636
[TBL] [Abstract][Full Text] [Related]
80. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
